loadpatents
Patent applications and USPTO patent grants for Renes; Johan.The latest application filed is for "multi-specific binding molecules targeting aberrant cells".
Patent | Date |
---|---|
Multi-specific Binding Molecules Targeting Aberrant Cells App 20210355209 - Willemsen; Ralph Alexander ;   et al. | 2021-11-18 |
Multi-specific binding molecules targeting aberrant cells Grant 11,098,115 - Willemsen , et al. August 24, 2 | 2021-08-24 |
Methods And Means For Attracting Immune Effector Cells To Tumor Cells App 20210238543 - Renes; Johan ;   et al. | 2021-08-05 |
Aberrant Cell-restricted Immunoglobulins Provided With A Toxic Moiety App 20210205465 - Renes; Johan ;   et al. | 2021-07-08 |
Aberrant cell-restricted immunoglobulins provided with a toxic moiety Grant 10,946,104 - Renes , et al. March 16, 2 | 2021-03-16 |
Binding Molecules Targeting Pathogens App 20200339669 - Renes; Johan ;   et al. | 2020-10-29 |
Aberrant Cell-restricted Immunoglobulins Provided With A Toxic Moiety App 20180154013 - Renes; Johan ;   et al. | 2018-06-07 |
Binding Molecules Targeting Pathogens App 20180105587 - Renes; Johan ;   et al. | 2018-04-19 |
Polypeptide That Binds Aberrant Cells And Induces Apoptosis App 20180071398 - Willemsen; Ralph Alexander ;   et al. | 2018-03-15 |
Polypeptide that binds aberrant cells and induces apoptosis Grant 9,821,073 - Willemsen , et al. November 21, 2 | 2017-11-21 |
Aberrant Cell-restricted Immunoglobulins Provided With A Toxic Moiety App 20150202318 - RENES; JOHAN ;   et al. | 2015-07-23 |
Binding Molecules Targeting Pathogens App 20150175683 - Renes; Johan ;   et al. | 2015-06-25 |
Aberrant Cell-restricted Immunoglobulins Provided With A Toxic Moiety App 20150056198 - Renes; Johan ;   et al. | 2015-02-26 |
Methods and Means for Clinical Investigations App 20140336475 - Renes; Johan | 2014-11-13 |
Multi-specific Binding Molecules Targeting Aberrant Cells App 20140227273 - Willemsen; Ralph Alexander ;   et al. | 2014-08-14 |
Polypeptide That Binds Aberrant Cells And Induces Apoptosis App 20140205599 - Willemsen; Ralph Alexander ;   et al. | 2014-07-24 |
Aberrant Cell-restricted Immunoglobulins Provided With A Toxic Moiety App 20130183307 - Renes; Johan ;   et al. | 2013-07-18 |
Separation Insurance System App 20130046564 - Veldhuizen; Mark ;   et al. | 2013-02-21 |
Mortgage insurance system Grant 8,301,469 - Veldhuizen , et al. October 30, 2 | 2012-10-30 |
Methods and means for clinical investigations App 20120123218 - Renes; Johan | 2012-05-17 |
Cross-beta Structures As Carrier In Vaccines App 20110287047 - Bouma; Barend ;   et al. | 2011-11-24 |
Enhancement Of Immunogenicity Of Antigens App 20110052564 - Gebbink; Martijn Frans Ben Gerard ;   et al. | 2011-03-03 |
Immunogenic Compositions Capable Of Activating T-cells App 20110008376 - Gebbink; Martijn Frans Ben Gerard ;   et al. | 2011-01-13 |
Immunogenic compositions capable of activating T-cells App 20090191228 - Gebbink; Martijn Frans Ben Gerard ;   et al. | 2009-07-30 |
Immunogenic compositions App 20090142377 - Gebbink; Martijn Frans Ben Gerard ;   et al. | 2009-06-04 |
Signatory sequences App 20050282169 - Turner, Allen C. ;   et al. | 2005-12-22 |
Insurance for cessation of legal personal contract App 20030074231 - Renes, Johan ;   et al. | 2003-04-17 |
Fusion proteins for specific treatment of cancer and autoimmune diseases App 20020176860 - Noteborn, Mathieu Hubertus, M. ;   et al. | 2002-11-28 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.